221 related articles for article (PubMed ID: 25228544)
1. Establishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndrome.
McNamara NA; Gallup M; Porco TC
Invest Ophthalmol Vis Sci; 2014 Sep; 55(11):7079-84. PubMed ID: 25228544
[TBL] [Abstract][Full Text] [Related]
2. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.
Li S; Nikulina K; DeVoss J; Wu AJ; Strauss EC; Anderson MS; McNamara NA
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):34-41. PubMed ID: 18172072
[TBL] [Abstract][Full Text] [Related]
3. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
4. Quantification of conjunctival TNF-α in aqueous-deficient dry eye.
Caffery BE; Joyce E; Heynen ML; Ritter R; Jones LA; Senchyna M
Optom Vis Sci; 2014 Feb; 91(2):156-62. PubMed ID: 24343449
[TBL] [Abstract][Full Text] [Related]
5. MUC1 expression in Sjogren's syndrome, KCS, and control subjects.
Caffery B; Heynen ML; Joyce E; Jones L; Ritter R; Senchyna M
Mol Vis; 2010 Aug; 16():1720-7. PubMed ID: 20806091
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients.
Liang H; Kessal K; Rabut G; Daull P; Garrigue JS; Melik Parsadaniantz S; Docquier M; Baudouin C; Brignole-Baudouin F
Ocul Surf; 2019 Jul; 17(3):516-525. PubMed ID: 30905840
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome.
Chen YT; Nikulina K; Lazarev S; Bahrami AF; Noble LB; Gallup M; McNamara NA
Am J Pathol; 2010 Sep; 177(3):1333-43. PubMed ID: 20696775
[TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
11. Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease.
Kim YH; Li Z; Cui L; Li Y; Yoon HJ; Choi W; Lee JB; Liu Z; Yoon KC
Am J Ophthalmol; 2019 Apr; 200():150-160. PubMed ID: 30653959
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
[TBL] [Abstract][Full Text] [Related]
13. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
[TBL] [Abstract][Full Text] [Related]
14. Alterations of ocular surface gene expression in Sjögren's syndrome.
Jones DT; Monroy D; Ji Z; Pflugfelder SC
Adv Exp Med Biol; 1998; 438():533-6. PubMed ID: 9634933
[TBL] [Abstract][Full Text] [Related]
15. Pax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye disease.
Chen YT; Chen FY; Vijmasi T; Stephens DN; Gallup M; McNamara NA
PLoS One; 2013; 8(10):e77286. PubMed ID: 24143217
[TBL] [Abstract][Full Text] [Related]
16. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
17. Lysine Demethylase 1B Promotes Tear Secretion Disorder in Sjogren's Syndrome by Regulating the PAX6/CLU Axis.
Liu S; Tang S; Yang G; Li Q
J Mol Neurosci; 2023 Jan; 73(1):28-38. PubMed ID: 36542318
[TBL] [Abstract][Full Text] [Related]
18. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.
Pflugfelder SC; Tseng SC; Yoshino K; Monroy D; Felix C; Reis BL
Ophthalmology; 1997 Feb; 104(2):223-35. PubMed ID: 9052626
[TBL] [Abstract][Full Text] [Related]
19. Reduced Levels of Tear Lacritin Are Associated With Corneal Neuropathy in Patients With the Ocular Component of Sjögren's Syndrome.
McNamara NA; Ge S; Lee SM; Enghauser AM; Kuehl L; Chen FY; Gallup M; McKown RL
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5237-5243. PubMed ID: 27711909
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
